Zinc irreversibly damages major enzymes of energy production and antioxidant defense prior to mitochondrial permeability transition.
Recent observations point to the role played by Zn2+ as an inducer of neuronal death. Two Zn2+ targets have been identified that result in inhibition of mitochondrial respiration: the bc1 center and, more recently, alpha-ketoglutarate dehydrogenase. Zn2+ is also a mediator of oxidative stress, leading to mitochondrial failure, release of apoptotic peptides, and neuronal death. We now present evidence, by means of direct biochemical assays, that Zn2+ is imported through the Ca2+ uniporter and directly targets major enzymes of energy production (lipoamide dehydrogenase) and antioxidant defense (thioredoxin reductase and glutathione reductase). We demonstrate the following. (a) These matrix enzymes are rapidly inhibited by application of Zn2+ to intact mitochondria. (b) Delayed treatment with membrane-impermeable chelators has no effect, indicating rapid transport of biologically relevant quantities of Zn2+ into the matrix. (c) Membrane-permeable chelators stop but do not reverse enzyme inactivation. (d) Enzyme inhibition is rapid and irreversible and precedes the major changes associated with the mitochondrial permeability transition (MPT). (e) The extent and rate of enzyme inactivation linearly correlates with the MPT onset and propagation. (f) The Ca2+ uniporter blocker, Ruthenium Red, protects enzyme activities and delays pore opening up to 2 microm Zn2+. An additional, unidentified import route functions at higher Zn2+ concentrations. (g) No enzyme inactivation is observed for Ca2+-induced MPT. These observations strongly suggest that, unlike Ca2+, exogenous Zn2+ interferes with mitochondrial NADH production and directly alters redox protection in the matrix, contributing to mitochondrial dysfunction. Inactivation of these enzymes by Zn2+ is irreversible, and thus only their de novo synthesis can restore function, which may underlie persistent loss of oxidative carbohydrate metabolism following transient ischemia.
Gazaryan
Irina G
IG
Burke Medical Research Institute, White Plains, New York 10605, USA.
Krasinskaya
Inna P
IP
Kristal
Bruce S
BS
Brown
Abraham M
AM
D000818:Animals; D000975:Antioxidants / Q000502:physiology*; D002118:Calcium; D004734:Energy Metabolism; D004789:Enzyme Activation; D004798:Enzymes / Q000378:metabolism*; D007425:Intracellular Membranes; D008928:Mitochondria / Q000378:metabolism* / Q000648:ultrastructure; D009243:NAD / Q000096:biosynthesis; D010084:Oxidation-Reduction; D010539:Permeability; D051381:Rats; D015032:Zinc / Q000502:physiology*
D000975:Antioxidants; D004798:Enzymes; D009243:NAD; D015032:Zinc; D002118:Calcium